126 related articles for article (PubMed ID: 11482763)
21. Aliphatic and heterocyclic analogues of arecaidine propargyl ester. Structure-activity relationships of mono- and bivalent ligands at muscarinic M1 (M4), M2 and M3 receptor subtypes.
Moser U; Gubitz C; Galvan M; Immel-Sehr A; Lambrecht G; Mutshcler E
Arzneimittelforschung; 1995 Apr; 45(4):449-55. PubMed ID: 7779140
[TBL] [Abstract][Full Text] [Related]
22. M1 muscarinic receptor stimulation decreases aspartate release in the rat neostriatum.
Expósito I; Sanz B; Mora F
Neurochem Res; 1997 Dec; 22(12):1485-90. PubMed ID: 9357014
[TBL] [Abstract][Full Text] [Related]
23. On the functional role of muscarinic M2 receptors in cholinergic and purinergic responses in the rat urinary bladder.
Giglio D; Delbro DS; Tobin G
Eur J Pharmacol; 2001 Oct; 428(3):357-64. PubMed ID: 11689195
[TBL] [Abstract][Full Text] [Related]
24. Functional characterization of peripheral muscarinic subtypes in anesthetized cats.
Koss MC
Life Sci; 1997; 61(2):217-27. PubMed ID: 9217280
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacological parameters of muscarinic cholinoreceptors in skeletal muscles].
Naumenko NV; Malomuzh AI; Khairova RA; Zefirov AL; Urazaev AKh
Ross Fiziol Zh Im I M Sechenova; 2002 May; 88(5):619-26. PubMed ID: 12136730
[TBL] [Abstract][Full Text] [Related]
26. Biphasic dose-response curves to arecoline in rat atria-mediation by a single promiscuous receptor or two receptor subtypes?
Kenakin TP; Boselli C
Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):201-5. PubMed ID: 1944613
[TBL] [Abstract][Full Text] [Related]
27. A 24-h access I.V. self-administration schedule of morphine reinforcement and the estimation of recidivism: Pharmacological modification by arecoline.
Buccafusco JJ; Bain JN
Neuroscience; 2007 Nov; 149(3):487-98. PubMed ID: 17916413
[TBL] [Abstract][Full Text] [Related]
28. Role of muscarinic receptor subtypes in central antinociception.
Bartolini A; Ghelardini C; Fantetti L; Malcangio M; Malmberg-Aiello P; Giotti A
Br J Pharmacol; 1992 Jan; 105(1):77-82. PubMed ID: 1375858
[TBL] [Abstract][Full Text] [Related]
29. Pharmaceutical Assessment Suggests Locomotion Hyperactivity in Zebrafish Triggered by Arecoline Might Be Associated with Multiple Muscarinic Acetylcholine Receptors Activation.
Siregar P; Audira G; Feng LY; Lee JH; Santoso F; Yu WH; Lai YH; Li JH; Lin YT; Chen JR; Hsiao CD
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33916832
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide-dependent relaxation induced by M1 muscarinic receptor activation in the rat small intestine.
Olgart C; Iversen HH
Br J Pharmacol; 1999 May; 127(1):309-13. PubMed ID: 10369487
[TBL] [Abstract][Full Text] [Related]
31. Cholinergic modulation of electrogenic ion transport in different regions of the rat small intestine.
Przyborski SA; Levin RJ
J Pharm Pharmacol; 1997 Jul; 49(7):691-7. PubMed ID: 9255713
[TBL] [Abstract][Full Text] [Related]
32. Muscarinic receptor subtype involvement in brain cholinergic stimulation by intracerebroventricular neostigmine in sinoaortic denervated rats.
Taira CA
Gen Pharmacol; 1998 Oct; 31(4):583-8. PubMed ID: 9792219
[TBL] [Abstract][Full Text] [Related]
33. Modulation by adenosine of both muscarinic M1-facilitation and M2-inhibition of [3H]-acetylcholine release from the rat motor nerve terminals.
Oliveira L; Timóteo MA; Correia-de-Sá P
Eur J Neurosci; 2002 Jun; 15(11):1728-36. PubMed ID: 12081652
[TBL] [Abstract][Full Text] [Related]
34. Methoctramine moderately improves memory but pirenzepine disrupts performance in delayed non-matching to position test.
Aura J; Sirviö J; Riekkinen P
Eur J Pharmacol; 1997 Aug; 333(2-3):129-34. PubMed ID: 9314025
[TBL] [Abstract][Full Text] [Related]
35. Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors.
Hamrouni AM; Gudka N; Broadley KJ
Auton Autacoid Pharmacol; 2006 Jul; 26(3):275-84. PubMed ID: 16879493
[TBL] [Abstract][Full Text] [Related]
36. Activation of muscarinic M3-like receptors and beta-adrenoceptors, but not M2-like muscarinic receptors or alpha-adrenoceptors, directly modulates corticostriatal neurotransmission in vitro.
Niittykoski M; Ruotsalainen S; Haapalinna A; Larson J; Sirviö J
Neuroscience; 1999 Apr; 90(1):95-105. PubMed ID: 10188937
[TBL] [Abstract][Full Text] [Related]
37. M1 acetylcholine receptor stimulation increases the extracellular concentrations of glutamate and GABA in the medial prefrontal cortex of the rat.
Sanz B; Exposito I; Mora F
Neurochem Res; 1997 Mar; 22(3):281-6. PubMed ID: 9051662
[TBL] [Abstract][Full Text] [Related]
38. Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum.
Harsing LG; Zigmond MJ
Brain Res Bull; 1998 Apr; 45(6):607-13. PubMed ID: 9566505
[TBL] [Abstract][Full Text] [Related]
39. Selectivity of oxomemazine for the M1 muscarinic receptors.
Lee SW; Woo CW; Kim JG
Arch Pharm Res; 1994 Dec; 17(6):443-51. PubMed ID: 10319156
[TBL] [Abstract][Full Text] [Related]
40. No evidence for a role of muscarinic M2 receptors in functional antagonism in bovine trachea.
Roffel AF; Meurs H; Elzinga CR; Zaagsma J
Br J Pharmacol; 1995 Jun; 115(4):665-71. PubMed ID: 7582488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
